nVerses Capital »

Aeglea Biotherapeutics shares owned by nVerses Capital

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by nVerses Capital from 13F filings

Historical chart of nVerses Capital investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by nVerses Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by nVerses Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $15k 500 29.41

More positions owned by nVerses Capital